Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United Kingdom
51 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Birmingham, Cardiff, Dundee, Hull, Leeds, London, Londonderry, Manchester, Sutton
- Age
- 18 years and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Edinburgh, London
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Birmingham, London, Sutton
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Glasgow, Leicester, London, Manchester, Oxford
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 2Taking peopleNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Edinburgh, Leeds, London, Oxford
- Age
- 18 years and over
- People
- 163 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05702229 · EU 2024-510977-27-00 - Phase 1/2Taking peopleA Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- Where
- London, Manchester, Newcastle upon Tyne, Southampton
- Age
- 18 years and over
- People
- 167
- Run by
- Cancer Research UK
See details and how to joinNCT06380816 - No phaseTaking peopleUnderstanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)
- Where
- Abercynon, Bournemouth, Cambridge, Cardiff, Glasgow, Hull, London, Nottingham, Salford, Southampton, Swansea, Truro
- Age
- 16 years and over
- People
- 160
- Run by
- University Hospital Southampton NHS Foundation Trust
See details and how to joinNCT06440174 - No phaseNot yet taking people in United KingdomMRinRT: Swansea University and SWWCC Collaboration Study.
- Where
- Swansea
- Age
- 18 years and over
- People
- 165
- Run by
- Swansea Bay University Health Board
See details and how to joinNCT07365124 - No phaseTaking peopleCancer Loyalty Card Study 2 (CLOCS-2)
- Where
- London
- Age
- 18 years and over
- People
- 2,900
- Run by
- Imperial College London
See details and how to joinNCT06447064 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleWill a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
- Where
- Guildford
- People
- 50
- Run by
- University of Surrey
See details and how to joinNCT07375420 - Phase 1/2Taking peoplePhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
- Where
- Newcastle upon Tyne
- Age
- 18 years and over
- People
- 43 worldwide
- Run by
- One-carbon Therapeutics AB
See details and how to joinNCT07151040 · EU 2024-519639-40-00 - No phaseTaking peopleREVOLUTION Surgery (REVOLUTION Surgery)
- Where
- Edinburgh
- Age
- 18 years and over
- People
- 200
- Run by
- University of Edinburgh
See details and how to joinNCT05642819 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Age
- 18 years and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT06988475 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Cambridge, Glasgow, London, Manchester, Newcastle, Oxford, Sutton
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - No phaseNot yet taking people in United KingdomOmentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer
- Where
- Oxford
- Age
- 18 years and over
- People
- 654 worldwide
- Run by
- Amsterdam UMC
See details and how to joinNCT05180864 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- London, Manchester, Surrey Quays
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleVolatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
- Where
- Cardiff, Cottingham, Coventry, Leicester, Liverpool, London, Luton, Newcastle, Norwich, Oxford, Portsmouth
- Age
- 18 years to 90 years
- People
- 518
- Run by
- Imperial College London
See details and how to joinNCT06169163 - No phaseTerminatedCardiopulmonary Toxicity of Thoracic Radiotherapy
- Where
- Glasgow
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT03978377 - No phaseTaking peopleHypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma
- Where
- London
- Age
- 18 years to 90 years
- People
- 120
- Run by
- Imperial College London
See details and how to joinNCT06669663 - No phaseTaking peopleAugmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)
- Where
- London
- Age
- 18 years to 90 years
- People
- 648
- Run by
- Imperial College London
See details and how to joinNCT05412758 - Phase 3Not yet taking people in United KingdomPROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- University of Aarhus
See details and how to joinNCT05055648 - Phase 2Taking peopleDeveloping ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
- Where
- Belfast, Cambridge, Coventry, Derby, Dundee, Guildford, Hull, Leeds, London, Manchester, Oxford, Preston, Whitchurch
- Age
- 18 years and over
- People
- 25
- Run by
- University of Southampton
See details and how to joinNCT05965479 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Birmingham, London
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767